Effects of MK-3475 on the breast tumor microenvironment in triple negative breast cancer with and without intra-operative RT: a window of opportunity study.

Protocol: 
AAAQ7863
Phase: 
Pilot

Effects of MK-3475 on the breast tumor microenvironment in triple negative breast cancer with and without intra-operative RT: a window of opportunity study.

Are you Eligible? (Inclusion Criteria)

Participants must be/have:
- at least 21 years of age on the day of signing informed consent
- histologically proven invasive breast carcinoma with triple negative
receptor status
- no evidence of metastatic disease
- no prior chemotherapy, radiation therapy, or breast resection within 6
months of study entry
- adequate organ function

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States